Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)

Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)

US Patent 10111953 · Granted Oct 30, 2018

Estimated economic value: $237,793,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibi2024
Methods for reducing or eliminating the need for lipoprotein apheresis in patien2024
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Methods for altering body composition by administering a GDF8 inhibitor and an A2022
Methods for reducing lipoprotein(a) levels by administering an inhibitor of prop2021
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody2021
Methods for increasing lean body mass with resistance training and a GDF8 inhibi2021
Methods for reducing or eliminating the need for lipoprotein apheresis in patien2020
Methods for treating patients with heterozygous familial hypercholesterolemia (h2020
Methods for treating patients with heterozygous familial hypercholesterolemia (h2020
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK92019